Furan derivatives as ep4 receptor antagonists
A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or (ii) an optionally substituted C5-7 aryl; and the other of R2 and R5 is the other group; m and n can be 0 or 1, and m+n=1 or 2 RN...
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE |
| description | A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or (ii) an optionally substituted C5-7 aryl; and the other of R2 and R5 is the other group; m and n can be 0 or 1, and m+n=1 or 2 RN is H or optionally substituted C1-4 alkyl R3 is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C1-7 alkyl, C5-20 aryl, or NRN3RN4, where RN3 and RN4 are independently selected from optionally substituted C1-4 alkyl; or (iv) tetrazol-5-yl. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN1894231A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN1894231A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN1894231A3</originalsourceid><addsrcrecordid>eNrjZNB1Ky1KzFNISS3KLEssySxLLVZILFZILTBRKEpNTi0oyS9SSMwrSUzPz8ssLinmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxzn6GFpYmRsaGjsaEVQAAKmkpdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Furan derivatives as ep4 receptor antagonists</title><source>esp@cenet</source><creator>CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE</creator><creatorcontrib>CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE</creatorcontrib><description>A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or (ii) an optionally substituted C5-7 aryl; and the other of R2 and R5 is the other group; m and n can be 0 or 1, and m+n=1 or 2 RN is H or optionally substituted C1-4 alkyl R3 is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C1-7 alkyl, C5-20 aryl, or NRN3RN4, where RN3 and RN4 are independently selected from optionally substituted C1-4 alkyl; or (iv) tetrazol-5-yl.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070110&DB=EPODOC&CC=CN&NR=1894231A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,309,782,887,25571,76555</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070110&DB=EPODOC&CC=CN&NR=1894231A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE</creatorcontrib><title>Furan derivatives as ep4 receptor antagonists</title><description>A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or (ii) an optionally substituted C5-7 aryl; and the other of R2 and R5 is the other group; m and n can be 0 or 1, and m+n=1 or 2 RN is H or optionally substituted C1-4 alkyl R3 is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C1-7 alkyl, C5-20 aryl, or NRN3RN4, where RN3 and RN4 are independently selected from optionally substituted C1-4 alkyl; or (iv) tetrazol-5-yl.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB1Ky1KzFNISS3KLEssySxLLVZILFZILTBRKEpNTi0oyS9SSMwrSUzPz8ssLinmYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxzn6GFpYmRsaGjsaEVQAAKmkpdg</recordid><startdate>20070110</startdate><enddate>20070110</enddate><creator>CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE</creator><scope>EVB</scope></search><sort><creationdate>20070110</creationdate><title>Furan derivatives as ep4 receptor antagonists</title><author>CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN1894231A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CLARK DAVID EDWARD,HARRIS NEIL VICTOR,FENTON GARRY,HYND GEORGE,STUTTLE KEITH ALFRED JAMES,SUTTON JONATHAN MARK,OXFORD ALEXANDER WILLIAM,DAVIS RICHARDJON,COLEMAN ROBERT ALEXANDER,CLARK KENNETH LYLE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Furan derivatives as ep4 receptor antagonists</title><date>2007-01-10</date><risdate>2007</risdate><abstract>A compound of formula (I): or a salt, solvate and chemically protected form thereof, wherein one of R2 and R5 is: (i) H or an optionally substituted C1-4 alkyl group; or (ii) an optionally substituted C5-7 aryl; and the other of R2 and R5 is the other group; m and n can be 0 or 1, and m+n=1 or 2 RN is H or optionally substituted C1-4 alkyl R3 is either: (i) carboxy; (ii) a group of formula (II): (iii) a group of formula (III): wherein R is optionally substituted C1-7 alkyl, C5-20 aryl, or NRN3RN4, where RN3 and RN4 are independently selected from optionally substituted C1-4 alkyl; or (iv) tetrazol-5-yl.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_CN1894231A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Furan derivatives as ep4 receptor antagonists |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T13%3A43%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CLARK%20DAVID%20EDWARD,HARRIS%20NEIL%20VICTOR,FENTON%20GARRY,HYND%20GEORGE,STUTTLE%20KEITH%20ALFRED%20JAMES,SUTTON%20JONATHAN%20MARK,OXFORD%20ALEXANDER%20WILLIAM,DAVIS%20RICHARDJON,COLEMAN%20ROBERT%20ALEXANDER,CLARK%20KENNETH%20LYLE&rft.date=2007-01-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN1894231A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |